Access to Kidney Transplant of Obese Patients Beginning Dialysis

Obesity is in constant increase all over the world and affects 35% of the global population according to the World Health Organisation. It is associated with other cardiovascular risk factors (particularly hypertension and diabetes) and with high morbi-mortality. It is also responsible for an increase of the risk of developing chronic kidney diseases (CKD). In fact, obese patients represent 25% of the dialysis population and Picardy is one of the most affected areas. However, their access to kidney transplant is still restricted and the reasons are not completely understood.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Kidney Transplant Access Comorbidities Dialysis Obese Patients

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Amiens

Amiens, 80480, France

Location status: Recruiting

Location contact

Gabriel Choukroun, PR

SUB_INVESTIGATOR

Pauline Caillard, MD

CONTACT

[email protected]

03 22 45 58 66

Pierre-François Westeel, MD

SUB_INVESTIGATOR

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age over 18 years old.
Patients with BMI≥30 kg/m2 (for study population) and 25≤BMI≤30 kg/m2(for control population) one month after dialysis initiation.
Patients agree with their data collection.

Exclusion criteria

Patients with bariatric surgery history.
Patients needed dialysis for graft dysfunction.
Data loss.

Treatment and study plan

Primary outcomes

variation of pre-transplant status two years after the obese patients' dialysis initiation between both groups

Time frame: two years

Study contacts

Contact information is provided by the study sponsor or research team.

Pauline Caillard, MD

CONTACT

[email protected]

03 22 45 58 66

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Acronym: Transplantob

Important dates

Study start: 2021
Primary completion: 2026
Study completion: 2026
First posted: Feb 10, 2021
Registry last updated: Jun 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting